Physician profile
Morgan Lambert
NPI 1346894938
$4,262.84
in general payments reported to CMS, 2019-2025
38 companies · $985 in 2025
The $985 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $171 · 2023: $932 · 2024: $1,816 · 2025: $985.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,733.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $496.33 | 2023-2025 | Mounjaro, Zepbound, Jardiance |
| Abbvie INC. | $494.73 | 2021-2025 | |
| Pfizer INC. | $492.99 | 2023-2025 | |
| Novo Nordisk INC | $405.67 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $405.41 | 2023-2025 | |
| Dexcom, INC. | $212.61 | 2024-2025 | Dexcom G6 Transmitter |
| Astrazeneca Pharmaceuticals LP | $174.34 | 2021-2025 | Farxiga, Airsupra, Breztri |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $163.84 | 2022-2025 | Xifaxan |
| Glaxosmithkline, LLC. | $150.47 | 2023-2024 | Trelegy Ellipta, Shingrix, Arexvy |
| Amgen INC. | $149.54 | 2023-2024 | Repatha, Otezla, Krystexxa |
| Exact Sciences Corporation | $148.24 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $137.82 | 2021-2024 | Veozah |
| Shield Therapeutics INC | $81.09 | 2023-2024 | Accrufer |
| Ardelyx, INC. | $70.19 | 2024-2025 | Ibsrela |
| Eisai INC. | $62.62 | 2024 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morgan Lambert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.